Ortho Conferences are still important, not for sales leads, but they tell us who launches.
OTA in Nashville put pelvic plates, automated frames, and fibula nails on the floor, while ICSES in Vancouver filled shoulder trays with knotless anchors, handheld robotics, and a new surgeon-research portal.
Smith+Nephew cleared the LANDMARK Total Knee for CORI and launched EVOS PELVIC the same week. Xenix planted a nanotech flag in spinopelvic fixation. OrthAlign crossed half a million joint cases on handheld enabling tech that hospitals and ASCs can actually afford.
On the capital side, Novadip’s €10.4M convertible kept a rare-disease bone-repair Phase 3 funded, and Redefine Surgery closed an oversubscribed pre-seed bringing total capital raised to $10M while locking Catalyst OrthoScience as a founding shoulder partner. Synergy Disc moved from SMISS slides into Spine Open peer review. Apollo’s roughly $20B conversation around J&J’s DePuy Synthes business stayed talks, not ink—while DePuy’s OTA booth stayed loud on trauma product.
The market paid for cleared trays, registry-scale enabling tech, and regenerative checks with a Phase 3 use of proceeds. It did not pay for another unsigned P...
